Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08NYO
|
|||
| Former ID |
DNC001107
|
|||
| Drug Name |
PDGF gene therapy
|
|||
| Synonyms |
UNII-54FF09J702; 54FF09J702; Ancriviroc besylate; SCH-351125 Besylate; 565428-86-6; (1,4'-Bipiperidine)-4-methanimine, alpha-(4-bromophenyl)-1'-((2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-N-ethoxy-4'-methyl-, (alphaZ)-, benzenesulfonate
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Diabetic foot ulcer [ICD-11: BD54; ICD-9: 707] | Investigative | [1] | |
| Company |
Selective Genetics
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C34H43BrN4O6S
|
|||
| Canonical SMILES |
CCON=C(C1CCN(CC1)C2(CCN(CC2)C(=O)C3=C(C=C[N+](=C3C)[O-])C)C)C4=CC=C(C=C4)Br.C1=CC=C(C=C1)S(=O)(=O)O
|
|||
| InChI |
1S/C28H37BrN4O3.C6H6O3S/c1-5-36-30-26(22-6-8-24(29)9-7-22)23-11-15-32(16-12-23)28(4)13-18-31(19-14-28)27(34)25-20(2)10-17-33(35)21(25)3;7-10(8,9)6-4-2-1-3-5-6/h6-10,17,23H,5,11-16,18-19H2,1-4H3;1-5H,(H,7,8,9)/b30-26+;
|
|||
| InChIKey |
RVIRPEALZXBUMV-REAKUJNMSA-N
|
|||
| CAS Number |
CAS 565428-86-6
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Platelet-derived growth factor receptor (PDGFR) | Target Info | Activator | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Emerging drugs for diabetic foot ulcers. Expert Opin Emerg Drugs. 2006 Nov;11(4):709-24. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.